Old Web
English
Sign In
Acemap
>
authorDetail
>
Shengchun Wang
Shengchun Wang
Fox Chase Cancer Center
Ibrutinib
Cancer research
Medicine
Minimal residual disease
Bruton's tyrosine kinase
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SHP1 Loss Augments DLBCL Cellular Response to Ibrutinib: A Candidate Predictive Biomarker
2021
Blood
Y. Lynn Wang
Ji Ma
Vinay Mallikarjuna
Pin Lu
Shengchun Wang
Sahar Poureghbali
Mariusz A. Wasik
Reza Nejati
Wenjun Wu
Show All
Source
Cite
Save
Citations (0)
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication
2021
Blood Cancer Journal
Pin Lu
Shengchun Wang
Carrie A. Franzen
Girish Venkataraman
Rebecca F. McClure
Lei Li
Wenjun Wu
Nifang Niu
Madina Sukhanova
Jianming Pei
Donald A. Baldwin
Reza Nejati
Mariusz A. Wasik
Nadia Khan
Yifan Tu
Juehua Gao
Yi-Hua Chen
Shuo Ma
Richard A. Larson
Y. Lynn Wang
Show All
Source
Cite
Save
Citations (1)
Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication
2019
Blood
Y. Lynn Lynn Wang
Carrie Franzen
Shengchun Wang
Girish Venkataraman
Lei Li
Nifang Niu
Madina Sukhanova
Yifan Tu
Juehua Gao
Yi-Hua Chen
Shuo Ma
Richard A. Larson
Lu Pin
Show All
Source
Cite
Save
Citations (2)
1